TURNING INVISIBLE RISKS INTO MEASURABLE TRUST.

150 million people worldwide rely on insulin – without knowing if it’s working as it should.

Every day, medicines lose their power silently, through heat, handling, and time.

We are devoloping a novel test with the power to shift healthcare beyond disease diagnostic, by making medication quality visible.

Trusting insulin shouldn’t be blind.

Everyday factors like heat, handling, and time silently affect insulin’s performance. Yet patients, caregivers, and clinicians have no way to know if it still works.

LUMIQ makes the invisible visible, bringing real-time trust back to life-saving medicine.

Explore LUMIQ

Reactive care vs. verified decisions with LUMIQ.

The problem is not temperature impact alone; it is decision-making under uncertainty.

Cold-chain data and temperature tracker shows risk. LUMIQ shows whether insulin quality is still intact.

Anker 1

Where innovation meets molecular biology.

Our journey began within the INSPIRE LAB at the Diabetes Center Berne, where we developed innovative methods to assess real-time insulin activity. Today, as a spin-off, we are transforming these insights into a pioneering solution for patients worldwide.

LEARN MORE

Federal Councillor Viola Amherd visits INSPIRE Lab 2024

OUR TECH.

Using advanced LFA technology and AI optical readout interpretation, we transform the smartphone camera into a lab-grade medical device (patent pending).

LEARN MORE